281 related articles for article (PubMed ID: 25367833)
1. Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome.
Yokouchi H; Baba T; Misawa S; Sawai S; Beppu M; Kitahashi M; Oshitari T; Kuwabara S; Yamamoto S
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1641-6. PubMed ID: 25367833
[TBL] [Abstract][Full Text] [Related]
2. Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome.
Yokouchi H; Baba T; Misawa S; Kitahashi M; Oshitari T; Kuwabara S; Yamamoto S
Br J Ophthalmol; 2017 Jun; 101(6):786-790. PubMed ID: 27707692
[TBL] [Abstract][Full Text] [Related]
3. Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome.
Yokouchi H; Baba T; Misawa S; Sawai S; Kitahashi M; Oshitari T; Kuwabara S; Yamamoto S
Br J Ophthalmol; 2016 Jul; 100(7):897-901. PubMed ID: 26504179
[TBL] [Abstract][Full Text] [Related]
4. Correlation of changes in serum level of VEGF and peripapillary retinal thickness in patients with POEMS syndrome.
Yokouchi H; Baba T; Misawa S; Oshitari T; Kuwabara S; Yamamoto S
Br J Ophthalmol; 2020 Jan; 104(1):33-38. PubMed ID: 30914422
[TBL] [Abstract][Full Text] [Related]
5. Alterations in choroidal vascular structures due to serum levels of vascular endothelial growth factor in patients with POEMS syndrome.
Yokouchi H; Nagasato D; Mitamura Y; Egawa M; Tabuchi H; Misawa S; Kuwabara S; Baba T
Sci Rep; 2023 Jun; 13(1):10650. PubMed ID: 37391497
[TBL] [Abstract][Full Text] [Related]
6. Correlation of macular choroidal thickness with concentrations of aqueous vascular endothelial growth factor in high myopia.
Chen W; Song H; Xie S; Han Q; Tang X; Chu Y
Curr Eye Res; 2015 Mar; 40(3):307-13. PubMed ID: 25300046
[TBL] [Abstract][Full Text] [Related]
7. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization.
Ahn SJ; Park KH; Woo SJ
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418
[TBL] [Abstract][Full Text] [Related]
8. Choroidal thickness measurement in myopic eyes by enhanced depth optical coherence tomography.
Ho M; Liu DT; Chan VC; Lam DS
Ophthalmology; 2013 Sep; 120(9):1909-14. PubMed ID: 23683921
[TBL] [Abstract][Full Text] [Related]
9. Binarization of enhanced depth imaging optical coherence tomographic images of an eye with Wyburn-Mason syndrome: a case report.
Iwata A; Mitamura Y; Niki M; Semba K; Egawa M; Katome T; Sonoda S; Sakamoto T
BMC Ophthalmol; 2015 Mar; 15():19. PubMed ID: 25884956
[TBL] [Abstract][Full Text] [Related]
10. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
Hamzah F; Shinojima A; Mori R; Yuzawa M
BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
[TBL] [Abstract][Full Text] [Related]
11. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
[TBL] [Abstract][Full Text] [Related]
12. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema.
Rayess N; Rahimy E; Ying GS; Bagheri N; Ho AC; Regillo CD; Vander JF; Hsu J
Am J Ophthalmol; 2015 Jan; 159(1):85-91.e1-3. PubMed ID: 25261844
[TBL] [Abstract][Full Text] [Related]
13. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
[TBL] [Abstract][Full Text] [Related]
14. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration.
Kang HM; Kwon HJ; Yi JH; Lee CS; Lee SC
Am J Ophthalmol; 2014 May; 157(5):1013-21. PubMed ID: 24487050
[TBL] [Abstract][Full Text] [Related]
15. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
[TBL] [Abstract][Full Text] [Related]
16. Subfoveal choroidal thickness change after intravitreal ranibizumab for idiopathic choroidal neovascularization.
Cao XS; Peng XY; You QS; Zhang YP; Jonas JB
Retina; 2014 Aug; 34(8):1554-9. PubMed ID: 24667570
[TBL] [Abstract][Full Text] [Related]
17. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
[TBL] [Abstract][Full Text] [Related]
18. A case of POEMS syndrome with cystoid macular edema.
Imai H; Kusuhara S; Nakanishi Y; Teraoka Escaño MF; Yamamoto H; Tsukahara Y; Negi A
Am J Ophthalmol; 2005 Mar; 139(3):563-6. PubMed ID: 15767082
[TBL] [Abstract][Full Text] [Related]
19. QUANTITATIVE ANALYSIS OF STRUCTURAL ALTERATIONS IN THE CHOROID OF PATIENTS WITH ACTIVE BEHÇET UVEITIS.
Onal S; Uludag G; Oray M; Mengi E; Herbort CP; Akman M; Metin MM; Koc Akbay A; Tugal-Tutkun I
Retina; 2018 Apr; 38(4):828-840. PubMed ID: 28272284
[TBL] [Abstract][Full Text] [Related]
20. Association between choroidal morphology and anti-vascular endothelial growth factor treatment outcome in myopic choroidal neovascularization.
Ahn SJ; Woo SJ; Kim KE; Park KH
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2115-22. PubMed ID: 23462751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
